Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
BridgeBio Pharma, Inc. (BBIO)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Dec-31-22 | Dec-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 |
| | 10-Q | 8-K | 10-Q | | | 10-Q | 10-Q | 10-K |
| Assets |
| Cash and equivalents | 302.4 | 0.0 | 407.4 | | | 470.1 | 371.6 | 393.8 |
| Other current assets | 130.4 | 20.5 | 145.3 | | | 301.2 | 344.7 | 495.1 |
| Total current assets | 432.9 | 20.5 | 552.7 | | | 771.3 | 716.2 | 888.9 |
| Property, plant, and equipment, net | 13.0 | 13.0 | 13.6 | | | 16.9 | 17.2 | 30.1 |
| Intangibles | 27.5 | 27.5 | 28.1 | | | 29.9 | 30.5 | 44.9 |
| Other fixed assets | 20.4 | 20.4 | 20.8 | | | 31.3 | 35.3 | 33.0 |
| Total assets | 503.7 | 503.7 | 625.7 | | | 862.2 | 813.1 | 1,012.8 |
| |
| Accounts payable | 3.9 | 3.9 | 4.1 | | | 8.8 | 10.1 | 11.9 |
| Accrued expenses | 33.6 | | 22.9 | | | 38.8 | 20.9 | 43.8 |
| Short-term debt | 0.0 | 0.0 | 0.0 | | | 0.0 | 0.0 | 0.0 |
| Deferred revenues | 6.2 | | 6.7 | | | 7.2 | | |
| Other current liabilities | 66.5 | 102.5 | 63.0 | | | 86.4 | 72.5 | 79.4 |
| Total current liabilities | 110.1 | 106.3 | 96.6 | | | 141.2 | 103.5 | 135.1 |
| Long-term debt | | 440.5 | | | | | | |
| Other liabilities | 1,743.2 | 13.3 | 1,742.7 | | | 1,736.1 | 1,750.4 | 1,743.3 |
| Total liabilities | 1,853.3 | 560.2 | 1,839.3 | | | 1,877.2 | 1,853.8 | 1,878.4 |
| |
| Shareholders' equity [+] | -1,349.6 | -56.5 | -1,213.6 | | | -1,015.0 | -1,040.7 | -865.6 |
| Paid-in capital | 1,128.1 | | 1,106.6 | | | 893.0 | 867.6 | 841.5 |
| Retained earnings | -2,215.4 | | -2,057.5 | | | -1,643.2 | -1,633.4 | -1,437.0 |
| Treasury stock | 275.0 | | 275.0 | | | 275.0 | 275.0 | 275.0 |
| Tangible shareholders' equity | -1,377.2 | -84.0 | -1,241.7 | | | -1,044.9 | -1,071.2 | -910.5 |
|